Ads
related to: kadcyla indication- EMILIA Trial
See EMILIA Clinical Trial
Information on KADCYLA®.
- KATHERINE Trial
See Latest KATHERINE Clinical Trial
Information on KADCYLA®.
- Dosing & Admin Guide
Download The Guide To Learn More
About The Dosing Schedule.
- Important Safety Info
See Full Prescribing Information
Including Boxed Warnings.
- Dosing Recommendations
Learn More About Administering
KADCYLA® To Your Patients.
- Contact A Representative
Talk With A Representative
To Learn More About KADCYLA®.
- EMILIA Trial
Search results
Seagen's (SGEN) Breast Cancer Study on Tuksya Combo Meets Goal
Zacks via Yahoo Finance· 9 months agoSeagen Inc. SGEN announced positive top-line results from its late-stage HER2CLIMB-02 study,...
ImmunoGen (IMGN) Q2 Earnings and Revenues Miss Estimates
Zacks via Yahoo Finance· 2 years agoImmunoGen, Inc. IMGN incurred a loss of 24 cents per share for second-quarter 2022, wider than the...
Roche (RHHBY) Q3 Revenues Dip on Lower COVID-19-Related Sales
Zacks via Yahoo Finance· 2 years agoSwiss pharma giant Roche Holding AG’s RHHBY third-quarter revenues declined 6% to CHF 14.7 billion...
Roche's (RHHBY) 2022 Core Earnings Grow, 2023 Outlook Dismal
Zacks via Yahoo Finance· 1 year agoRoche Holding AG’s RHHBY performance in 2022 was pretty average, as the demand for COVID-19 products...
AstraZeneca (AZN) Drugs Get CHMP Recommendation for Breast Cancer
Zacks via Yahoo Finance· 2 years agoThe EMA's Committee for Medicinal Products for Human Use recommends granting marketing approval to...
ImmunoGen (IMGN) Ovarian Cancer Drug BLA Gets Priority Review
Zacks via Yahoo Finance· 2 years agoImmunoGen (IMGN) gets priority review from the FDA for the BLA seeking approval for its lead...
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Zacks via Yahoo Finance· 2 years agoShares of Puma Biotechnology PBYI were up 17.4% at market close on Aug 5, following the earnings...
Roche (RHHBY) 1H Revenues, Earnings Down on Lower COVID-19 Test Sales
Zacks via Yahoo Finance· 10 months agoRoche Holding AG’s RHHBY performance in the first half was average, as COVID-19 product related...
An Important History Lesson for Gene-Editing Investors
Motley Fool· 6 months agoThe history of biotechnology is full of examples of promising technologies that took decades to...
New data sets stage for broader use of AstraZeneca breast cancer drug
Reuters via Yahoo News· 2 years agoAstraZeneca and Daiichi Sankyo's Enhertu extended survival by more than six months in patients with...
Ads
related to: kadcyla indication
